These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30066578)

  • 1. Anticancer activities of a benzimidazole compound through sirtuin inhibition in colorectal cancer.
    Tan YJ; Lee YT; Yeong KY; Petersen SH; Kono K; Tan SC; Oon CE
    Future Med Chem; 2018 Sep; 10(17):2039-2057. PubMed ID: 30066578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BZD9L1 sirtuin inhibitor: Identification of key molecular targets and their biological functions in HCT 116 colorectal cancer cells.
    Tan YJ; Lee YT; Mancera RL; Oon CE
    Life Sci; 2021 Nov; 284():119747. PubMed ID: 34171380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BZD9L1 sirtuin inhibitor as a potential adjuvant for sensitization of colorectal cancer cells to 5-fluorouracil.
    Tan YJ; Lee YT; Petersen SH; Kaur G; Kono K; Tan SC; Majid AMSA; Oon CE
    Ther Adv Med Oncol; 2019; 11():1758835919878977. PubMed ID: 31632470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BZD9L1 benzimidazole analogue hampers colorectal tumor progression by impeding angiogenesis.
    Oon CE; Subramaniam AV; Ooi LY; Yehya AHS; Lee YT; Kaur G; Sasidharan S; Qiu B; Wang X
    World J Gastrointest Oncol; 2023 May; 15(5):810-827. PubMed ID: 37275453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facile construction of fused benzimidazole-isoquinolinones that induce cell-cycle arrest and apoptosis in colorectal cancer cells.
    He LJ; Yang DL; Li SQ; Zhang YJ; Tang Y; Lei J; Frett B; Lin HK; Li HY; Chen ZZ; Xu ZG
    Bioorg Med Chem; 2018 Aug; 26(14):3899-3908. PubMed ID: 29921474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crataegus azarolus Leaves Induce Antiproliferative Activity, Cell Cycle Arrest, and Apoptosis in Human HT-29 and HCT-116 Colorectal Cancer Cells.
    Mustapha N; Pinon A; Limami Y; Simon A; Ghedira K; Hennebelle T; Chekir-Ghedira L
    J Cell Biochem; 2016 May; 117(5):1262-72. PubMed ID: 26495895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy regulates Selumetinib (AZD6244) induced-apoptosis in colorectal cancer cells.
    Grasso S; Pereira GJS; Palmeira-Dos-Santos C; Calgarotto AK; Martínez-Lacaci I; Ferragut JA; Smaili SS; Bincoletto C
    Eur J Med Chem; 2016 Oct; 122():611-618. PubMed ID: 27448918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of death receptor, DR5 and mitochondria-mediated apoptosis by a 3,4,5-trimethoxybenzyloxy derivative in wild-type and p53 mutant colorectal cancer cell lines.
    Chan ZCK; Leong KH; Kareem HS; Norazit A; Noor SM; Ariffin A
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Mar; 393(3):405-417. PubMed ID: 31641820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer.
    Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH
    J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
    Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
    BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer.
    Vakana E; Pratt S; Blosser W; Dowless M; Simpson N; Yuan XJ; Jaken S; Manro J; Stephens J; Zhang Y; Huber L; Peng SB; Stancato LF
    Oncotarget; 2017 Feb; 8(6):9251-9266. PubMed ID: 27999210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riproximin: A type II ribosome inactivating protein with anti-neoplastic potential induces IL24/MDA-7 and GADD genes in colorectal cancer cell lines.
    Pervaiz A; Adwan H; Berger MR
    Int J Oncol; 2015 Sep; 47(3):981-90. PubMed ID: 26151662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties.
    Yoon YK; Ali MA; Wei AC; Shirazi AN; Parang K; Choon TS
    Eur J Med Chem; 2014 Aug; 83():448-54. PubMed ID: 24992072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined activation of K
    Pillozzi S; D'Amico M; Bartoli G; Gasparoli L; Petroni G; Crociani O; Marzo T; Guerriero A; Messori L; Severi M; Udisti R; Wulff H; Chandy KG; Becchetti A; Arcangeli A
    Br J Cancer; 2018 Jan; 118(2):200-212. PubMed ID: 29161243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
    Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
    Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
    Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
    Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
    El Khoury F; Corcos L; Durand S; Simon B; Le Jossic-Corcos C
    Int J Oncol; 2016 Dec; 49(6):2558-2568. PubMed ID: 27748801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical study of cinobufagin as a promising anti-colorectal cancer agent.
    Lu XS; Qiao YB; Li Y; Yang B; Chen MB; Xing CG
    Oncotarget; 2017 Jan; 8(1):988-998. PubMed ID: 27894091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer activity of novel pyrido[2,3-b]indolizine derivatives: the relevance of phenolic substituents.
    Boot A; Brito A; VAN Wezel T; Morreau H; Costa M; Proença F
    Anticancer Res; 2014 Apr; 34(4):1673-7. PubMed ID: 24692696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.